查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1889209

凝血分析仪市场预测至2032年：按产品、测试类型、模式、技术、最终用户和地区分類的全球分析

Coagulation Analyzers Market Forecasts to 2032 - Global Analysis By Product (Systems/Analyzers and Consumables), Test Type, Modality, Technology, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的一项研究，预计到 2025 年，全球凝血分析仪市场价值将达到 51.3 亿美元，到 2032 年将达到 83.5 亿美元，在预测期内的复合年增长率为 7.2%。

凝血分析仪是一种自动化诊断设备，用于评估血液凝固的效率和持续时间。它们透过检测凝血因子异常情况，辅助诊断血栓症、血友病和肝臟疾病等问题。透过PT、aPTT和D-二聚体等自动化测量，这些分析仪可提供可靠的数据，用于抗凝血治疗的管理，使医护人员能够快速做出明智的治疗决策。

根据珀斯血液研究所的数据，截至 2025 年 7 月，全球男性血友病患病率预计为 1/6,000 至 1/10,000（2024 年数据），其中 A 型血友病患病率约为 1/5,000，B 型血友病患病率约为 1/30,000。

抗凝血剂使用增加

随着越来越多的患者接受长期治疗，对凝血参数进行精确监测的需求日益增长。凝血分析仪在确保安全用药和有效治疗方面发挥关键作用。医院和诊断中心正越来越多地采用先进的分析仪来辅助制定个人化治疗方案。老年人口的成长（老年人更容易发生血栓症）也进一步推动了市场扩张。因此，抗凝血治疗的激增是推动凝血分析仪市场成长的主要因素。

发展中地区缺乏意识和基础设施

许多医疗机构缺乏支援先进诊断设备所需的基础设施。高成本和不完善的报销政策阻碍了对现代分析设备的投资。医护人员训练不足也限制了现有技术的有效利用。农村和医疗资源匮乏地区往往依赖基础诊断方法，降低了市场渗透率。因此，新兴经济体在认知度和基础设施方面的不足持续限制经济成长。

扩大照护现场检测（POC​​检测）的使用

携带式分析仪使临床医生能够即时做出治疗决策，从而改善患者预后。对分散式医疗保健日益增长的需求正在推动便携式分析仪在居家医疗和急诊环境中的应用。技术创新正在提高即时检测 (POC) 设备的准确性和易用性。政府和私人医疗机构正在投资 POC 解决方案，以扩大服务不足地区的医疗覆盖范围。这一成长趋势为製造商拓展市场提供了重要机会。

替代产品的威胁

由于成本原因，一些医疗机构依赖人工检测和简易试剂盒。分子诊断和影像领域的新兴技术可能会减少对传统分析仪的依赖。成熟的替代方案通常具有使用者熟悉度高、训练要求低的优势。在价格敏感型市场，儘管这些替代方案的准确性较低，但仍可能受到青睐。因此，替代产品的威胁仍然是市场持续成长面临的主要风险因素。

新冠疫情的影响：

新冠疫情扰乱了供应链，延误了常规诊断流程，并影响了对分析仪的需求。然而，这场危机凸显了血液凝固检验在重症病例管理中的重要性。医院已采用快速检测方案来监测新冠患者的凝血併发症。远距离诊断和分散式检查在封锁期间备受关注。疫情后的策略现在强调韧性、数位整合以及更广泛地普及凝血分析仪。

在预测期内，凝血酶原时间（PT）细分市场将占据最大的市场份额。

由于凝血酶原时间 (PT) 在监测抗凝血治疗中发挥重要作用，预计在预测期内，PT 检测将占据最大的市场份额。 PT 检测广泛用于评估服用Warfarin及类似药物患者的凝血功能。其在心血管和血液系统疾病的临床效用确保了其稳定的需求。医院和诊断中心将 PT 检测作为常规监测和急诊护理的首选。 PT 检测的简单性和可靠性使其成为全球首选。

在预测期内，电化学技术领域将实现最高的复合年增长率。

由于其准确性和高效性，电化学技术领域预计将在预测期内实现最高成长率。这些分析仪能够以极少的检体量快速检测凝血参数。感测器设计和微流体技术的进步提高了性能和可靠性。携带式电化学设备在照护现场环境中越来越受欢迎。其成本效益和扩充性使其在已开发市场和新兴市场都极具吸引力。

占比最大的地区：

由于北美拥有先进的医疗基础设施和较高的健康意识，预计在预测期内，北美将占据最大的市场份额。该地区抗凝血治疗和常规凝血监测的普及率很高，而优惠的报销政策也促进了先进分析设备的广泛应用。主要製造商的总部设在美国，确保了北美能够方便地取得技术创新。持续的研发投入正在巩固该地区的技术领先地位。

年复合成长率最高的地区：

预计亚太地区在预测期内将实现最高的复合年增长率，这主要得益于医疗基础设施的不断改进和患者数量的持续增长。中国和印度等国家正在大力投资诊断技术的现代化。人们对凝血障碍的认识不断提高，推动了对先进检测解决方案的需求。政府主导的措施和公私合营正在提升医疗服务的可近性和可负担性。该地区庞大的人口规模和心血管疾病盛行率的不断上升进一步增强了其成长潜力。

免费客製化服务：

订阅本报告的用户可从以下免费自订选项中选择一项：

  • 公司简介
    • 对最多三家其他公司进行全面分析
    • 对主要企业进行SWOT分析（最多3家公司）
  • 区域分类
    • 根据客户兴趣对主要国家进行市场估算、预测和复合年增长率分析（註：基于可行性检查）
  • 竞争基准化分析
    • 基于产品系列、地域覆盖和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 引言

  • 概述
  • 相关利益者
  • 分析范围
  • 分析方法
  • 分析材料

第三章 市场趋势分析

  • 司机
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 终端用户分析
  • 新兴市场
  • 新冠疫情的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代产品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球凝血分析仪市场（依产品划分）

  • 系统/分析仪
    • 全自动系统
    • 半自动系统
    • 手动系统
    • PoC测试分析仪
  • 消耗品
    • 试剂
    • 侦测
    • 标准产品
    • 控制
    • 校对

6. 全球凝血分析仪市场（依检验类型划分）

  • 凝血酶原时间（PT）
  • 活化部份凝血活酵素时间（APTT）
  • 纤维蛋白原检测
  • D-二聚体检测
  • 抗凝血酶III试验
  • 其他特殊血液凝固检验

7. 全球凝血分析仪市场（依模式划分）

  • 中央检查室平台
  • PoC（照护现场）平台

8. 全球凝血分析仪市场（依技术划分）

  • 光学技术
  • 机械技术
  • 电化学技术
  • 其他技术

9. 全球凝血分析仪市场（依最终用户划分）

  • 医院
  • 临床检查室
  • 诊断中心
  • 研究所
  • 其他最终用户

第十章 全球凝血分析仪市场（依地区划分）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美国家
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章：主要趋势

  • 合约、商业伙伴关係和合资企业
  • 企业合併（M&A）
  • 新产品上市
  • 业务拓展
  • 其他关键策略

第十二章 企业概况

  • Siemens Healthineers
  • Bio-Rad Laboratories
  • Sysmex Corporation
  • ERBA Mannheim
  • Roche Diagnostics
  • Diagnostica Stago
  • Abbott Laboratories
  • Trinity Biotech
  • Thermo Fisher Scientific
  • Helena Laboratories
  • Instrumentation Laboratory
  • Nihon Kohden Corporation
  • Beckman Coulter
  • Mindray Medical International
  • Horiba Medical
Product Code: SMRC32669

According to Stratistics MRC, the Global Coagulation Analyzers Market is accounted for $5.13 billion in 2025 and is expected to reach $8.35 billion by 2032 growing at a CAGR of 7.2% during the forecast period. Coagulation analyzers are automated diagnostic devices that evaluate the efficiency and timing of blood clot formation. They perform tests that identify abnormalities in clotting factors and assist in diagnosing issues like thrombosis, hemophilia, and liver-related disorders. Through automated assays such as PT, aPTT, and D-dimer, these analyzers provide reliable data for managing anticoagulant therapy, enabling healthcare professionals to make informed and rapid treatment decisions.

According to the Perth Blood Institute, as of July 2025, the prevalence of hemophilia in the male population worldwide was 1 in 6,000-10,000 in 2024, with hemophilia A affecting approximately 1 in 5,000 males and hemophilia B affecting approximately 1 in 30,000 males.

Market Dynamics:

Driver:

Increase in anticoagulant therapy use

As more patients undergo long-term treatment, the need for precise monitoring of coagulation parameters has intensified. Coagulation analyzers play a critical role in ensuring safe dosage and effective therapy outcomes. Hospitals and diagnostic centers are increasingly adopting advanced analyzers to support personalized treatment regimens. The growing elderly population, which is more prone to thrombotic conditions, further accelerates market expansion. Consequently, the surge in anticoagulant therapy use is a primary driver of growth in the coagulation analyzers market.

Restraint:

Limited awareness and infrastructure in developing regions

Many healthcare facilities lack adequate infrastructure to support advanced diagnostic equipment. High costs and insufficient reimbursement policies discourage investment in modern analyzers. Training gaps among medical professionals also hinder effective utilization of available technologies. Rural and underserved areas often rely on basic diagnostic methods, reducing market penetration. As a result, limited awareness and infrastructure continue to restrain growth in emerging economies.

Opportunity:

Increasing adoption of point-of-care (POC) testing

Portable analyzers allow clinicians to make immediate treatment decisions, improving patient outcomes. Rising demand for decentralized healthcare is driving adoption in homecare and emergency settings. Technological innovations are enhancing accuracy and usability of POC devices. Governments and private providers are investing in POC solutions to expand access in underserved regions. This growing trend represents a significant opportunity for manufacturers to broaden their market reach.

Threat:

Threat of substitute products

Some healthcare providers rely on manual testing or basic kits due to lower costs. Emerging technologies in molecular diagnostics and imaging may reduce dependence on traditional analyzers. Established substitutes often benefit from familiarity and lower training requirements. Price-sensitive markets may prefer these alternatives despite lower accuracy. Consequently, the threat of substitute products remains a notable risk for sustained market growth.

Covid-19 Impact:

The COVID-19 pandemic disrupted supply chains and delayed routine diagnostic procedures, affecting analyzer demand. However, the crisis highlighted the importance of coagulation testing in managing severe cases. Hospitals adopted rapid testing solutions to monitor clotting complications in COVID-19 patients. Remote diagnostics and decentralized testing gained traction during lockdowns. Post-pandemic strategies now emphasize resilience, digital integration, and wider accessibility of coagulation analyzers.

The prothrombin time (PT) segment is expected to be the largest during the forecast period

The prothrombin time (PT) segment is expected to account for the largest market share during the forecast period, due to its critical role in monitoring anticoagulant therapy. PT testing is widely used to assess clotting function in patients on warfarin and similar drugs. Its clinical relevance across cardiovascular and hematological conditions ensures consistent demand. Hospitals and diagnostic centers prioritize PT testing for routine monitoring and emergency care. The simplicity and reliability of PT assays make them a preferred choice globally.

The electrochemical technology segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the electrochemical technology segment is predicted to witness the highest growth rate, due to its precision and efficiency. These analyzers offer rapid detection of clotting parameters with minimal sample volumes. Advances in sensor design and microfluidics are enhancing performance and reliability. Portable electrochemical devices are gaining popularity in point-of-care settings. Their cost-effectiveness and scalability make them attractive for both developed and emerging markets.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, driven by advanced healthcare infrastructure and high awareness. The region benefits from strong adoption of anticoagulant therapies and routine coagulation monitoring. Favorable reimbursement policies support widespread use of advanced analyzers. Leading manufacturers are headquartered in the U.S., ensuring easy access to innovations. Continuous investment in R&D strengthens technological leadership in the region.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, fueled by expanding healthcare infrastructure and rising patient volumes. Countries such as China and India are investing heavily in diagnostic modernization. Growing awareness of coagulation disorders is driving demand for advanced testing solutions. Government initiatives and public-private partnerships are fostering accessibility and affordability. The region's large population base and increasing prevalence of cardiovascular diseases amplify growth potential.

Key players in the market

Some of the key players in Coagulation Analyzers Market include Siemens H, Bio-Rad La, Sysmex Co, ERBA Man, Roche Dia, Diagnosti, Abbott Lab, Trinity Bio, Thermo Fi, Helena La, Instrumen, Nihon Koh, Beckman C, Mindray Me, and Horiba M.

Key Developments:

In November 2025, Siemens and Samsung C&T Corporation, Engineering & Construction Group have entered a strategic and long-term partnership. Grounded in mutual trust and complementary capabilities, the agreement aims to combine Samsung C&T's global engineering, procurement, and construction (EPC) expertise with Siemens' advanced technologies in automation, digitalization, electrification, and integrated infrastructure intelligence.

In July 2025, Bio-Rad Laboratories, Inc. announced the launch of four new Droplet Digital(TM) PCR (ddPCR(TM)) platforms. The newly introduced instruments include Bio-Rad's QX Continuum(TM) ddPCR system along with the QX700(TM) series of ddPCR platforms acquired as part of the company's recently completed acquisition of digital PCR developer Stilla Technologies.

Products Covered:

  • Systems/Analyzers
  • Consumables

Test Types Covered:

  • Prothrombin Time (PT)
  • Activated Partial Thromboplastin Time (APTT)
  • Fibrinogen Testing
  • D-Dimer Testing
  • Anti-Thrombin III Testing
  • Other Specialized Coagulation Tests

Modalities Covered:

  • Central Laboratory Platforms
  • Point-of-Care Platforms

Technologies Covered:

  • Optical Technology
  • Mechanical Technology
  • Electrochemical Technology
  • Other Technologies

End Users Covered:

  • Hospitals
  • Clinical Laboratories
  • Diagnostic Centers
  • Research Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Coagulation Analyzers Market, By Product

  • 5.1 Introduction
  • 5.2 Systems/Analyzers
    • 5.2.1 Automated Systems
    • 5.2.2 Semi-automated Systems
    • 5.2.3 Manual Systems
    • 5.2.4 Point-of-Care Testing Analyzers
  • 5.3 Consumables
    • 5.3.1 Reagents
    • 5.3.2 Assays
    • 5.3.3 Standards
    • 5.3.4 Controls
    • 5.3.5 Calibrations

6 Global Coagulation Analyzers Market, By Test Type

  • 6.1 Introduction
  • 6.2 Prothrombin Time (PT)
  • 6.3 Activated Partial Thromboplastin Time (APTT)
  • 6.4 Fibrinogen Testing
  • 6.5 D-Dimer Testing
  • 6.6 Anti-Thrombin III Testing
  • 6.7 Other Specialized Coagulation Tests

7 Global Coagulation Analyzers Market, By Modality

  • 7.1 Introduction
  • 7.2 Central Laboratory Platforms
  • 7.3 Point-of-Care Platforms

8 Global Coagulation Analyzers Market, By Technology

  • 8.1 Introduction
  • 8.2 Optical Technology
  • 8.3 Mechanical Technology
  • 8.4 Electrochemical Technology
  • 8.5 Other Technologies

9 Global Coagulation Analyzers Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Clinical Laboratories
  • 9.4 Diagnostic Centers
  • 9.5 Research Institutes
  • 9.6 Other End Users

10 Global Coagulation Analyzers Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Siemens Healthineers
  • 12.2 Bio-Rad Laboratories
  • 12.3 Sysmex Corporation
  • 12.4 ERBA Mannheim
  • 12.5 Roche Diagnostics
  • 12.6 Diagnostica Stago
  • 12.7 Abbott Laboratories
  • 12.8 Trinity Biotech
  • 12.9 Thermo Fisher Scientific
  • 12.10 Helena Laboratories
  • 12.11 Instrumentation Laboratory
  • 12.12 Nihon Kohden Corporation
  • 12.13 Beckman Coulter
  • 12.14 Mindray Medical International
  • 12.15 Horiba Medical

List of Tables

  • Table 1 Global Coagulation Analyzers Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Coagulation Analyzers Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Coagulation Analyzers Market Outlook, By Systems/Analyzers (2024-2032) ($MN)
  • Table 4 Global Coagulation Analyzers Market Outlook, By Automated Systems (2024-2032) ($MN)
  • Table 5 Global Coagulation Analyzers Market Outlook, By Semi-automated Systems (2024-2032) ($MN)
  • Table 6 Global Coagulation Analyzers Market Outlook, By Manual Systems (2024-2032) ($MN)
  • Table 7 Global Coagulation Analyzers Market Outlook, By Point-of-Care Testing Analyzers (2024-2032) ($MN)
  • Table 8 Global Coagulation Analyzers Market Outlook, By Consumables (2024-2032) ($MN)
  • Table 9 Global Coagulation Analyzers Market Outlook, By Reagents (2024-2032) ($MN)
  • Table 10 Global Coagulation Analyzers Market Outlook, By Assays (2024-2032) ($MN)
  • Table 11 Global Coagulation Analyzers Market Outlook, By Standards (2024-2032) ($MN)
  • Table 12 Global Coagulation Analyzers Market Outlook, By Controls (2024-2032) ($MN)
  • Table 13 Global Coagulation Analyzers Market Outlook, By Calibrations (2024-2032) ($MN)
  • Table 14 Global Coagulation Analyzers Market Outlook, By Test Type (2024-2032) ($MN)
  • Table 15 Global Coagulation Analyzers Market Outlook, By Prothrombin Time (PT) (2024-2032) ($MN)
  • Table 16 Global Coagulation Analyzers Market Outlook, By Activated Partial Thromboplastin Time (APTT) (2024-2032) ($MN)
  • Table 17 Global Coagulation Analyzers Market Outlook, By Fibrinogen Testing (2024-2032) ($MN)
  • Table 18 Global Coagulation Analyzers Market Outlook, By D-Dimer Testing (2024-2032) ($MN)
  • Table 19 Global Coagulation Analyzers Market Outlook, By Anti-Thrombin III Testing (2024-2032) ($MN)
  • Table 20 Global Coagulation Analyzers Market Outlook, By Other Specialized Coagulation Tests (2024-2032) ($MN)
  • Table 21 Global Coagulation Analyzers Market Outlook, By Modality (2024-2032) ($MN)
  • Table 22 Global Coagulation Analyzers Market Outlook, By Central Laboratory Platforms (2024-2032) ($MN)
  • Table 23 Global Coagulation Analyzers Market Outlook, By Point-of-Care Platforms (2024-2032) ($MN)
  • Table 24 Global Coagulation Analyzers Market Outlook, By Technology (2024-2032) ($MN)
  • Table 25 Global Coagulation Analyzers Market Outlook, By Optical Technology (2024-2032) ($MN)
  • Table 26 Global Coagulation Analyzers Market Outlook, By Mechanical Technology (2024-2032) ($MN)
  • Table 27 Global Coagulation Analyzers Market Outlook, By Electrochemical Technology (2024-2032) ($MN)
  • Table 28 Global Coagulation Analyzers Market Outlook, By Other Technologies (2024-2032) ($MN)
  • Table 29 Global Coagulation Analyzers Market Outlook, By End User (2024-2032) ($MN)
  • Table 30 Global Coagulation Analyzers Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 31 Global Coagulation Analyzers Market Outlook, By Clinical Laboratories (2024-2032) ($MN)
  • Table 32 Global Coagulation Analyzers Market Outlook, By Diagnostic Centers (2024-2032) ($MN)
  • Table 33 Global Coagulation Analyzers Market Outlook, By Research Institutes (2024-2032) ($MN)
  • Table 34 Global Coagulation Analyzers Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.